Inmune Bio, Inc. (35) | Business Finance (12)
Browse by Subcategory
Recent Contracts
-
Form of Securities Purchase Agreement
(Filed With SEC on March 24, 2022)
-
Warrant to Purchase Common Stock issued to SVB Innovation Credit Fund VIII, L.P
(Filed With SEC on June 15, 2021)
-
Loan and Security Agreement
(Filed With SEC on June 15, 2021)
-
Warrant to Purchase Common Stock issued to Silicon Valley Bank
(Filed With SEC on June 15, 2021)
-
Underwriting Agreement, dated July 16, 2020, by and between INmune Bio, Inc. and BTIG, Inc., as representative of the underwriters named therein
(Filed With SEC on July 16, 2020)
-
Common Stock Repurchase Agreement
(Filed With SEC on January 27, 2020)
-
Registration Rights Agreement between INmune Bio Inc. and Lincoln Park Capital Fund, LLC, dated May 15, 2019
(Filed With SEC on May 16, 2019)
-
Form of Securities Purchase Agreement
(Filed With SEC on July 15, 2021)
-
Amendment No. 2 to Securities Purchase Agreement between INmune Bio, Inc. and Raymond J. Tesi
(Filed With SEC on May 24, 2019)
-
Amendment to Securities Purchase Agreement between INmune Bio, Inc. and Raymond J. Tesi
(Filed With SEC on May 17, 2019)
-
Amendment to Securities Purchase Agreement between INmune Bio, Inc. and David J. Moss
(Filed With SEC on May 17, 2019)
-
Purchase Agreement between INmune Bio Inc. and Lincoln Park Capital Fund, LLC, dated May 15, 2019
(Filed With SEC on May 16, 2019)